Ingles Markets
IMKTA
85.17
-0.25
-0.29%
Ingles Markets
US · IMKTA
#2934 by market cap
Listed 1970
85.17
-0.25
-0.29%
Live - 5344 symbols - heartbeat 499s ago
· 2026-10-07 19:54
After-hours
85.17
0.00%
- Market cap
- 1.62B
- P/E (TTM)i
- 15.57
- P/Bi
- 0.96
- EPSi
- 4.40
- Div yieldi
- 0.77%
- 52W posi
- 64%
Reader sentiment
Are you bullish or bearish on IMKTA?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 4.48, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -5.42% YoY
Margins
- Gross margin
- 23.89%
- Operating margin
- 2.73%
- Net margin
- 1.57%
Key ratios & quality
- Enterprise valuei
- 1.77B
- Altman Z-Scorei
- 4.48
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.09B | 4.20B | 4.61B | 4.99B | 5.68B | 5.89B | 5.64B | 5.33B |
| Gross profit | 980.17M | 1.02B | 1.20B | 1.30B | 1.42B | 1.40B | 1.30B | 1.27B |
| Selling & admin expenses | -- | -- | -- | 11.10M | 10.90M | 10.60M | 9.70M | 7.40M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 124.10M | 148.14M | 276.50M | 340.10M | 375.57M | 289.53M | 142.54M | 145.60M |
| Pretax profit | 80.32M | 106.60M | 235.04M | 327.61M | 361.27M | 278.50M | 139.50M | 109.94M |
| Tax | -17.05M | 25.02M | 56.44M | 77.88M | 88.51M | 67.69M | 33.96M | 26.35M |
| Net profit | 97.36M | 81.58M | 178.60M | 249.73M | 272.76M | 210.81M | 105.54M | 83.59M |
| Basic EPS | 5 | 4 | 9 | 13 | 15 | 11 | 6 | 5 |
| Diluted EPS | 4.81 | 4.03 | 8.82 | 12.73 | 14.36 | 11.10 | 5.56 | 4.40 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.33B | 1.35B | 1.37B | 1.37B | 1.31B | 1.37B |
| Gross profit | 310.98M | 327.33M | 334.70M | 334.56M | 325.26M | 332.44M |
| Selling & admin expenses | -- | -- | -- | -- | -- | -- |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 21.83M | 37.20M | 66.14M | 39.14M | 34.11M | 34.44M |
| Pretax profit | 19.60M | 35.25M | 33.22M | 37.45M | 32.74M | 33.02M |
| Tax | 4.50M | 9.06M | 7.52M | 9.32M | 8.47M | 7.12M |
| Net profit | 15.11M | 26.20M | 25.70M | 28.13M | 24.27M | 25.90M |
| Basic EPS | 1 | 1 | 1 | 2 | 1 | 1 |
| Diluted EPS | 0.80 | 1.38 | 1.35 | 1.48 | 1.28 | 1.36 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 496.74M | 497.10M | 470.19M | 575.44M | 838.13M | 952.56M | 925.55M | 975.56M |
| Cash & ST investments | 10.54M | 42.13M | 6.90M | 75.31M | 267.20M | 328.54M | 353.69M | 366.25M |
| Inventory | 372.20M | 374.13M | 366.82M | 389.95M | 457.95M | 493.86M | 462.08M | 482.98M |
| Total assets | 1.82B | 1.87B | 1.90B | 2.02B | 2.30B | 2.47B | 2.53B | 2.57B |
| Total current liabilities | 260.14M | 247.58M | 323.81M | 306.10M | 333.78M | 330.53M | 320.62M | 302.90M |
| Short-term debt | 12.85M | 12.60M | 27.69M | 26.24M | 25.42M | 25.76M | 23.19M | 23.16M |
| Long-term debt | 852.74M | 839.64M | 586.20M | 571.91M | 554.29M | 532.63M | 515.10M | 497.29M |
| Total liabilities | 1,229,497,012.00 | 1,204,605,762.00 | 1,079,967,945.00 | 1,035,085,417.00 | 1,035,916,300.00 | 1,014,873,593.00 | 982,133,625.00 | 950,123,066.00 |
| Total equity | 595.41M | 662.72M | 819.33M | 983.26M | 1.26B | 1.46B | 1.55B | 1.62B |
| Retained earnings | 582.09M | 650.66M | 816.26M | 985.73M | 1.25B | 1.44B | 1.54B | 1.61B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 909.16M | 947.67M | 975.56M | 977.12M | 1.02B | 1.06B |
| Cash & ST investments | 297.33M | 336.09M | 366.25M | 361.68M | 418.00M | 455.09M |
| Inventory | 491.18M | 487.54M | 482.98M | 485.29M | 479.41M | 479.65M |
| Total assets | 2.51B | 2.55B | 2.57B | 2.57B | 2.59B | 2.63B |
| Total current liabilities | 285.41M | 301.42M | 302.90M | 290.97M | 304.94M | 329.21M |
| Short-term debt | 23.04M | 23.05M | 23.16M | 23.10M | 22.81M | 22.96M |
| Long-term debt | 504.07M | 500.56M | 497.29M | 494.05M | 486.28M | 483.05M |
| Total liabilities | 934,608,825.00 | 953,292,377.00 | 950,123,066.00 | 930,265,355.00 | 932,913,530.00 | 948,712,986.00 |
| Total equity | 1.57B | 1.59B | 1.62B | 1.64B | 1.66B | 1.68B |
| Retained earnings | 1.56B | 1.59B | 1.61B | 1.63B | 1.66B | 1.68B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 161.24M | 211.50M | 350.12M | 306.30M | 339.50M | 266.41M | 262.52M | 154.10M |
| Depreciation & amortization | 113.08M | 112.52M | 116.28M | 117.10M | 117.80M | 115.98M | 121.62M | 122.89M |
| Free cash flow | 10.75M | 49.75M | 227.35M | 165.70M | 219.89M | 92.82M | 51.66M | 39.60M |
| Dividends paid | -13.00M | -13.01M | -13.01M | -12.63M | -12.26M | -12.26M | -12.27M | -12.27M |
| Stock buybacks / issuance | -- | -- | 0 | -80.00M | -- | -- | -- | -- |
| Ending cash balance | 10.54M | 42.13M | 6.90M | 70.31M | 267.20M | 328.54M | 353.69M | 366.25M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 63.06M | 74.79M | 59.90M | 38.41M | 83.80M | 66.98M |
| Depreciation & amortization | 30.60M | 30.68M | 30.68M | 30.29M | 30.07M | 30.10M |
| Free cash flow | 38.86M | 45.38M | 36.78M | 2.05M | 67.12M | 43.62M |
| Dividends paid | -3.07M | -3.07M | -3.07M | -3.07M | -3.07M | -3.07M |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 297.33M | 336.09M | 366.25M | 361.68M | 418.00M | 455.09M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 17.60 | 12.97 | 24.10 | 27.71 | 24.32 | 15.51 | 7.03 | 5.29 |
| ROA %i | 5.47 | 4.42 | 9.48 | 12.75 | 12.65 | 8.84 | 4.22 | 3.28 |
| ROIC %i | 9.27 | 7.92 | 14.01 | 17.37 | 16.57 | 11.59 | 5.86 | 4.62 |
| 5-year avg ROE %i | 13.65 | 13.65 | 15.54 | 18.67 | 21.34 | 20.92 | 19.73 | 15.97 |
| EBIT margin %i | 3.12 | 3.67 | 5.98 | 7.06 | 6.74 | 5.10 | 2.86 | 2.43 |
| FCF / sales %i | 0.26 | 1.18 | 4.93 | 3.32 | 3.87 | 1.58 | 0.92 | 0.74 |
| Current ratioi | 1.91 | 2.01 | 1.45 | 1.88 | 2.51 | 2.88 | 2.89 | 3.22 |
| Quick ratioi | 0.31 | 0.46 | 0.27 | 0.56 | 1.09 | 1.32 | 1.35 | 1.56 |
| Debt / assetsi | 47.43 | 45.64 | 34.48 | 31.31 | 26.68 | 24.07 | 22.35 | 21.19 |
| LT debt / equityi | 143.22 | 126.70 | 76.55 | 61.61 | 46.61 | 39.05 | 35.05 | 32.21 |
| Interest coveragei | 2.69 | 3.25 | 6.80 | 14.46 | 17.80 | 13.62 | 7.38 | 6.58 |
| Revenue CAGR (3Y) %i | 2.70 | 3.45 | 4.83 | 6.82 | 10.56 | 8.52 | 4.18 | -2.07 |
| Net income CAGR (3Y) %i | 17.94 | 14.61 | 49.11 | 36.89 | 49.53 | 5.68 | -24.96 | -32.58 |
| FCF CAGR (3Y) %i | -39.85 | 32.50 | 99.47 | 148.84 | 64.11 | -25.82 | -32.19 | -43.53 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 4.00 | 3.58 | 5.29 | 5.94 | 6.45 | 6.34 |
| ROA %i | 2.48 | 2.22 | 3.28 | 3.76 | 4.09 | 4.01 |
| ROIC %i | 3.67 | 3.36 | 4.62 | 5.11 | 5.49 | 5.43 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 1.87 | 1.75 | 2.43 | 2.67 | 2.92 | 2.86 |
| FCF / sales %i | 0.40 | 0.15 | 0.74 | 2.27 | 2.80 | 2.76 |
| Current ratioi | 3.19 | 3.14 | 3.22 | 3.36 | 3.34 | 3.21 |
| Quick ratioi | 1.39 | 1.45 | 1.56 | 1.62 | 1.70 | 1.69 |
| Debt / assetsi | 22.07 | 21.52 | 21.19 | 20.97 | 20.44 | 20.00 |
| LT debt / equityi | 33.72 | 32.95 | 32.21 | 31.45 | 30.54 | 29.89 |
| Interest coveragei | 4.95 | 4.70 | 6.58 | 7.50 | 8.33 | 8.35 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Retail grocery revenue is the largest reported line at 95.75% of revenue, across 2 reported segments.
- The next-largest line, All other revenue, is a distant second at 4.25% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Retail grocery revenue95.75%
All other revenue4.25%
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.